| A | immunocompetent Acanthamoeba spp. infected mice |
| ADAM | adamalysin-like proteinases |
| AM 22 | amoebic strain no. 22 |
| AML | acute myeloid leukemia |
| AS | immunosuppressed Acanthamoeba spp. infected mice |
| BBB | blood brain barrier |
| BCA | bicinchoninic acid |
| C | immunocompetent uninfected control group mice |
| cAMP | cyclic adenosine monophosphate |
| CNS | central nervous system |
| COX-2 | cyclooxygenase-2 |
| CS | immunosuppressed uninfected mice |
| CSF | cerebrospinal fluid |
| Dpi | day post infection |
| GAE | granulomatous amebic encephalitis |
| GCL | granular cell layer |
| HIV | human immunodeficiency virus |
| IHC | Immunohistochemistry |
| IL-1 | interleukin 1 |
| IL-6 | interleukin 6 |
| IL-23 | interleukin 23 |
| LTP | long term potentiation |
| MMPs | matrix metalloproteinases |
| MMP-2 | matrix metalloproteinase-2 |
| MMP-9 | matrix metalloproteinase-9 |
| MPS | methylprednisolone sodium succinate |
| NK | natural killers |
| PBS | phosphate-buffered saline |
| PDGF | platelet-derived growth factor |
| PGE2 | Prostaglandin E2 |
| PKDL | Post-kala-azar dermal leishmaniasis |
| PyrCL | pyramidal cell layer |
| SD | standard deviation |
| TACE/ADAM17 | ADAM metallopeptidase domain 17 |
| TGF-β | transforming growth factor—β |
| TIMP | tissue inhibitor of metalloproteinase |
| TIMP-1 | tissue inhibitor of metalloproteinase-1 |
| TIMP-3 | tissue inhibitor of metalloproteinase-3 |
| TNF | tumor necrosis factor |
| TNF-α | tumor necrosis factor—α |